Study to Identify the Reduction of Exacerbations Resulting in Hospital Admission in Patients With COPD.
Completed
- Conditions
- COPD Exacerbation
- Registration Number
- NCT05440188
- Lead Sponsor
- Universidad Autonoma de Madrid
- Brief Summary
identification of the reduction of exacerbations resulting in hospital admission in COPD patients after the use of the Breath Detect telemedicine platform.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
- COPD diagnosed in GOLD II state or higher
Exclusion Criteria
- Can´t read and talk in spanish
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Number of hospital admissions due to exacerbations 24 weeks
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie COPD exacerbation reduction via Breath Detect telemedicine?
How does Breath Detect telemedicine compare to standard-of-care in preventing COPD hospitalizations?
Are there specific biomarkers that predict COPD patient response to telemedicine platforms like Breath Detect?
What adverse events are associated with telemedicine-based COPD management and how are they managed?
What are the potential combination approaches for Breath Detect with existing COPD therapies like bronchodilators or inhaled corticosteroids?
Trial Locations
- Locations (1)
CS Entrevías
🇪🇸Madrid, Spain
CS Entrevías🇪🇸Madrid, Spain